EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biofilm Production and Its Implications in Pediatrics

Nicola Principi iD, Susanna Esposito iD

Microorganisms · 25.07.2024 · 12 (8) · 1522

DOI: 10.3390/microorganisms12081522 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 25.07.2024. Verfasst von Nicola Principi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Università degli Studi di Milano, 20122 Milan, Italy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biofilms, aggregates of bacteria enclosed in a self-produced matrix, have been implicated in various pediatric respiratory infections, including acute otitis media (AOM), otitis media with effusion (OME), adenoiditis, protracted bacterial bronchitis, and pulmonary exacerbations in cystic fibrosis. These infections are prevalent in children and often associated with biofilm-producing pathogens, leading to recurrent and chronic conditions. Biofilms reduce antibiotic efficacy, contributing to treatment failure and disease persistence. This narrative review discusses biofilm production by respiratory pathogens such as Streptococcus pneumoniae, non-typeable Haemophilus influenzae, Pseudomonas aeruginosa, and Staphylococcus aureus. It examines their mechanisms of biofilm formation, antibiotic resistance, and the challenges they present in clinical treatment. Various antibiofilm strategies have shown promise in vitro and in animal studies, including the use of N-acetylcysteine, enzymes like dispersin B, and agents disrupting quorum sensing and biofilm matrix components. However, their clinical application, particularly in children, remains limited. Traditional treatments for biofilm-associated diseases have not significantly evolved, even with biofilm detection. The transition from experimental findings to clinical practice is complex and requires robust clinical trials and standardized biofilm detection protocols. Addressing biofilms in pediatric respiratory infections is crucial for improving treatment outcomes and managing recurrent and chronic diseases effectively.

Schlagwörter

Stichwörter der Autor:innen

acute otitis mediaadenoiditisbiofilmcystic fibrosisotitis media with effusionprotracted bacterial bronchitis

Autor:innen und Institutionen

  • Università degli Studi di Milano, 20122 Milan, Italy.
  • Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.

ORCID-Profile: Nicola Principi, Susanna Esposito

Zitieren

APA

Principi, N., & Esposito, S. (2024). Biofilm Production and Its Implications in Pediatrics. Microorganisms, 12(8), 1522. https://doi.org/10.3390/microorganisms12081522

Vancouver

Principi N, Esposito S. Biofilm Production and Its Implications in Pediatrics. Microorganisms. 2024;12(8):1522. doi:10.3390/microorganisms12081522

BibTeX
@article{Principi2024,
  author = {Principi, Nicola and Esposito, Susanna},
  title = {Biofilm Production and Its Implications in Pediatrics},
  journal = {Microorganisms},
  year = {2024},
  volume = {12},
  number = {8},
  pages = {1522},
  doi = {10.3390/microorganisms12081522}
}
Kostenlos starten →